Volume 7, Number 6—December 2001
Dispatch
Malaria in Illegal Chinese Immigrants, Italy
Table
No. | Sex,age (yrs) | Origin | Countries visited | Day/mo of initial visit | Malaria species | Parasite density | Days until hospital dxa | Clinical signs & symptoms | Treatment | Outcome |
---|---|---|---|---|---|---|---|---|---|---|
1 | M, 24 | Na | Pakistan | 1/7 | Pf | <1% | 0 | Uncomplicated | Quinine + Doxycycline | Resolved |
2 | F, 20 | Na | Na | 3/7 | Pf | 15% | 0 | Uncomplicated | Mefloquine | Resolved |
3 | M, 26 | Na | Na | 3/7 | Pf | 15% | 0 | Uncomplicated | Mefloquine | Resolved |
4 | M, 20 | Zhe Jiang | Laos, Myanmar, Bangladesh, Pakistan, East Africa | 5/7 | Pf | <1% | 2 | Uncomplicated | Quinine + Doxycycline | Resolved |
5 | M, 29 | Southern China | Pakistan, Myanmar, Thailand | 5/7 | Pf | <1% | 1 | Uncomplicated | Quinine + Doxycycline | Resolved |
6 | M, 23 | Na | Vietnam, Cambodia, Kenya | 17/7 | Pf | 20% | 2 | Severe | Quinine + Doxycycline | Death |
7 | M, 19 | Zhe Jiang | Pakistan, Ivory Coast | 19/7 | Pf | 3% | 2 | Severe | Quinine + antifolics; transfusion | Resolved |
8 | M, 33 | Na | Pakistan | 20/7 | Pv | Nd2 | 0 | Nd3 | Chloroquine | Resolved |
9 | M, 23 | Na | Na | 20/7 | Pf | 2.5% | 0 | Uncomplicated | Mefloquine | Resolved |
10 | F, ? | Na | Pakistan | 21/7 | Pf | 20% | 3 | Severe | Quinine + Doxycycline Exchange transfusion | Resolved |
11 | M, 26 | Na | Na | 22/7 | Pf | <1% | 0 | Uncomplicated | Quinine | Self discharged |
12 | M, 28 | Na | Tanzania | 22/7 | Pf | 11% | 4 | Severe | Quinine + Clindamicin | Resolved |
13 | F, 28 | Na | Na | 26/7 | Pf + Po | 10% | 3 | Severe | Quinine + Doxycycline Primaquine | Resolved |
14 | M, 24 | Zhe Jiang | Laos, Myanmar, Bangladesh, Pakistan, East Africa | 27/7 | Pf | <1% | 0 | Uncomplicated | Quinine + Doxycycline | Resolved |
15 | M, 25 | Zhe Jiang | Laos, Myanmar, Bangladesh, Pakistan, East Africa | 28/7 | Pf | 15% | 8 | Severe | Quinine + Doxycycline Exchange transfusion | Neurologic sequelae |
16 | M, 22 | Zhe Jiang | East Africa | 28/7 | Pf | <1% | 0 | Uncomplicated | Quinine | Resolved |
17 | M, 18 | Na | Myanmar, Bangladesh, Pakistan, Ivory Coast, France | 2/8 | Pf | <1% | 1 | Uncomplicated | Quinine + Doxycycline | Resolved |
18 | F, 19 | Southern China | Kenya | 6/8 | Pf | 1% | 11 | Uncomplicated | Quinine + Doxycycline | Resolved |
19 | M, 29 | Na | Pakistan | 7/8 | Pf | 1% | 0 | Uncomplicated | Quinine + Doxycycline | Resolved |
20 | F, 24 | Zhe Jiang | Ivory Coast | 6/9 | Pf | 17% | 2 | Severe | Quinine + Doxycycline Exchange transfusion | Resolved |
21 | M, 29 | Southern China | Pakistan, Ivory Coast | 11/9 | Pf | <1% | 0 | Uncomplicated | Quinine + Doxycycline | Resolved |
22 | M, 18 | Na | Cameroon | 15/11 | Pf | <1% | 0 | Uncomplicated | Mefloquine | Resolved |
A value of 0 indicates diagnosis on the day of admission.
F = female; M = male; dx = diagnosis; mo = month; Na = not assessed; Nd = not determined in a case of Plasmodium vivax infection; Pv = P. vivax; Pf = P. falciparum; Po = P. ovale.
Page created: December 09, 2010
Page updated: December 09, 2010
Page reviewed: December 09, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.